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Abstract 
The major source of morbidity following cardiopulmonary bypass (CPB) is the systemic inflam-
matory response (SIRS response) which leads to multiple derangements in different organ sys-
tems. To combat this, miniaturized cardiopulmonary bypass circuits (MCPBC) have been created 
to lessen the inflammatory response to CPB. Here we examine early outcomes following coronary 
artery bypass grafting (CABG) using a MCPBC system compared to conventional bypass techniques 
at a single institution. Methods: 60 consecutive patients undergoing elective CABG were prospec-
tively enrolled. Nine patients underwent coronary artery bypass grafting (CABG) with convention-
al CPB (cCABG), 33 underwent off-pump CABG (OPCAB), and the remaining 18 patients underwent 
CABG with a MCPBC system. Demographics and outcomes were compared between groups and 
statistical analyses applied. Results: No significant difference was observed in mortality between 
groups, with only one death reported in total. Morbidity was also low, totaling only 6.7%, with 
none occurring in the MCPBC group. The MCPBC group required less PRBC and total blood product 
transfusion than the cCABG and OPCABG groups (p = 0.05), but changes in PLT and Hct over time 
were not different between groups. Conclusions: The MCPBC system was shown to be comparable 
to conventional bypass and OPCABG in terms of postoperative complications and mortality. Fur-
thermore, the MCPBC system had the advantage of a decreased transfusion requirement. Based on 
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our preliminary observations, this mini-cardiopulmonary bypass circuit provides a safe alterna-
tive to conventional bypass techniques. 
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1. Introduction 
The development of cardiopulmonary bypass machines (CPB) in the 1950’s revolutionized the field of cardiac 
surgery [1], and for the first time allowed surgeons to directly address intracardiac disease processes. Today, 
coronary artery revascularization (CABG) can be performed with a mortality rate less than 3% [2] [3], using the 
gold-standard technique of CABG with extracorporeal bypass. However, despite these good outcomes, CABG 
procedures still have significant morbidities associated with them including bleeding, thromboembolic events, 
arrhythmias, neurological insults, and renal and hepatic dysfunction [4]-[6]. Many of these events occur as a di-
rect result of the systemic inflammatory response syndrome (SIRS) that is caused by the use of CPB [7].  
In an effort to reduce the negative effects of CPB, many strategies and concepts have evolved in the recent 
years, including the development of off-pump coronary bypass (OPCABG) to remove CPB from the procedure 
completely. However, OPCABG has its own limitations, primarily hemodynamic instability during surgery, 
technical difficulty, and long-term graft patency remaining a subject of debate. As a result, less than 25% of all 
CABG procedures are currently performed off-pump [8]. 
Another strategy to reduce the deleterious effects of CPB has been the development of minimized circuits 
[9]-[14]. The goal of these mini-cardiopulmonary bypass circuits (MCPBC) has been to minimize the contact 
between blood and foreign material, as this contact has been proposed as the inciting event that triggers much of 
the SIRS in the patient. MCPBC are closed circuit devices that serve the same purpose as traditional CPB, with 
several important changes. MCPBCs have no open venous reservoir to eliminate air-blood contact, reduced tub-
ing length to lower required priming volume, heparinized tubing, and, perhaps most importantly, cardiotomy 
suction is eliminated. Here we seek to evaluate the potential advantages of the MCPBC system compared to 
conventional CPB and OPCABG at a single Veteran’s Affairs hospital. 
2. Materials and Methods 
We prospectively enrolled 72 patients undergoing cardiac surgery after written informed consent was obtained. 
This group included 12 patients undergoing valve repair/replacement (9 Aortic, 2 Mitral, 1 Tricuspid), which 
were not included for analysis here but are discussed further below. In total, 60 patients underwent isolated elec-
tive coronary artery revascularization, and all were included in analysis. Nine patients underwent CABG using 
conventional cardiopulmonary bypass (cCABG), with 4 receiving a beating heart on-pump procedure (BHOP). 
Thirty-three underwent off-pump coronary bypass grafting (OPCAB) using our standard technique. The re-
maining 18 patients had CABG using a miniaturized extracorporeal circuit (MCPBC), of which 11 had the pro-
cedure performed with full cardiac arrest and 7 received BHOP procedures. 
2.1. Mini Pump Circuit Description 
We utilized the NovoSci Ready System 200, a closed loop extracorporeal system containing the Jostra RotaFlow 
centrifugal pump (Eresing, Germany). This system has a Jostra arterial filter, a Quadrox (Maquet, Germany) 
oxygenator, and a closed bag reservoir (Figure 1). Priming volume of the system is 1000 ml; however, by using 
a retrograde autologous prime (RAP) [15] this is decreased to 500 - 600 ml. The RotaFlow system features inte-
grated level and bubble sensors for added safety (Figure 1). Blood from the surgical field was collected in a 
cell-saving device, but no cardiotomy suction was utilized.  
2.2. Conventional Circuit Description 
The cCABG circuit used was a Stockert S5 system with a Stockert 3T heater/cooler system (Sorin group; Arva- 
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Figure 1. Diagram of the novosci ready system 200.                                                             
 
da, CO), which was set up and run in a conventional fashion. This has been our standard approach and system 
for some time. The priming volume is approximately 1700 ml for this system. 
2.3. Statistical Analysis 
To compare groups, the Chi-square test was used for categorical data and a t-test was used for continuous data. 
Generalized Estimating Equation (GEE) models were used to examine the effect of pump types on with-
in-subject change of HCT and PLT over time (preoperative and postoperative), corrected for the covariates sex, 
age, BMI, smoker, renal failure, and HTN; all other data is uncorrected. A p value of <0.05 was considered sta-
tistically significant throughout. Analyses were performed using SAS software (SAS Institute Inc., Minneapolis, 
MN) with the assistance of our in-house statistician. 
3. Results  
Demographic data and pre-operative risk factors were similar between all three groups, with the exception of 
renal dysfunction which was more common in the off-pump group (Table 1).  
The cross-clamp time and duration of cardiopulmonary bypass were not statistically different between the 
cCABG and MCPBC groups, nor was the use of the Cell Saver, though this was used less in OPCABG cases 
(Table 2). 
Patients in the MCPBC group were transfused fewer packed red blood cells (PRBC) than the patients in the 
cCABG or OPCABG groups (0.4 v. 2.9 and 1.0 units, respectively, p = 0.05). Transfusion of other blood prod-
ucts, fresh frozen plasma (FFP) and platelets (PLT), were also less within the MCPBC group as compared to the 
cCABG and OPCABG groups (FFP-0 vs. 1.3 and 0.18; PLT-0 vs. 0.11 and 0.06, respectively), though this was 
not statistically significant (Table 2). Despite the differences in amount of transfusions between groups, the 
changes in the PLT and Hct over time (preoperatively v. postoperatively), as examined using GEE modeling, 
were not found to be significantly different among the groups (p > 0.1 for both PLT and Hct). 
Length of stay was shortest in the MCPBC group, but this was not statistically significant (cCABG-11.9, 
MCPBC-6.8, OPCABG-10.4 days, p = 0.492). The overall rate of composite morbidity (including death, peri-
operative MI, new renal failure, mediastinits, cardiac arrest, reoperation for bleeding, prolonged ventilation, new 
CVA, or coma) was very low, with a total of four patients (6.7%) suffering any morbidity, and only one death 
(1.7%). None of the patients in the MCPBC group developed a morbidity, and three in the OPCABG and one in  
D. Emerson et al. 
 
 235 
Table 1. Demographics.                                                                                   
 Conventional (n = 9) Novosci (n = 18) Off pump (n = 33) p 
Age (y) 63.3 (±4.5) 62.4 (±9.9) 65.2 (±9.4) 0.550 
BMI (kg/m2) 28.5 (±1.8) 28.4 (±5.4) 29.0 (±5.4) 0.923 
CVD 11% (1) 17% (3) 18% (6) 0.822 
DM 56% (5) 44% (8) 52% (17) 0.834 
HTN 100% (9) 94% (17) 88% (29) 0.445 
IABP 11% (1) 0% (0) 15% (5) 0.225 
LAD > 50% 22% (2) 28% (5) 24% (8) 0.941 
Prior CABG 0% (0) 0% (0) 6% (2) 0.429 
Renal failure 0% (0) 0% (0) 30% (10) 0.010 
Smoker 78% (7) 56% (10) 76% (25) 0.277 
Preoperative EF (%) 47.2 (±11.5) 48.6 (±11.6) 46.7 (±12.7; n = 32) 0.870 
 
Table 2. Operative data and outcomes.                                                                          
 Conventional (n = 9) Novosci (n = 18) Off pump (n = 33) p 
Cell saver used 78% (7) 56% (10) 3% (1) <0.0001 
Pump time (min) 90.1 (±45.0) 93.4 (±22.0) N/A 0.80 
Total PRBC (units) 2.9 (±5.0) 0.4 (±0.9) 1.0 (±1.9) 0.05 
Total FFP (units) 1.3 (±4.0) 0 (±0) 0.18 (±1.0) 0.14 
Total PLT (units) 0.11 (±0.3) 0 (±0) 0.06 (±0.4) 0.61 
Total product (units) 4.3 (±8.2) 0.4 (±0.9) 1.24 (±3.1) 0.05 
Hct change −3.7 (±5.6) −6.8 (±5.0) −4.8 (±4.2) 0.194 
PLT change −16.6 (±43.9) −35.6 (±46.0) −14.4 (±37.3) 0.208 
Death 0% 0% 3% (1) ns 
Composite morbidity 11% (1) 0% 12% (3) 0.46 
***Note-Data are presented as average (+ or − standard deviation), percentage of patients (actual number of patients), or average change (+ or − stan-
dard devation), as appropriate. 
 
the cCABG groups did; however, due to the low overall number, this was not statistically significant (p = 0.458). 
Due to the very low mortality rate (one death), further statistical analysis of mortality was not undertaken.  
4. Discussion 
Conventional cardiopulmonary bypass continues to provide the best technical conditions for the cardiac surgeon, 
but this bloodless, motionless field comes at the cost of additional morbidities related to the SIRS response 
[4]-[7]. Off-pump CABG has been established as an alternative to conventional bypass; however, the technical 
challenges have limited adoption, as have questions regarding long-term patency rates. Consequently, less than 
25% of all CABGs are currently performed off-pump [8].  
To address SIRS-associated conventional CPB morbidities, the miniaturized circuit has been introduced. The 
main advantage of the MCPBC system is reduction of the blood-foreign surface contact, which is believed to be 
the main culprit in activation of the complement cascade and cytokine production leading to a SIRS response 
[16]-[18]. Additionally, these circuits utilize heparin-coated tubing, which has been shown to reduce comple-
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ment activation and the subsequent inflammatory response [16]-[19]. Finally, reduction in hemodilution and 
hemolysis leads to lower transfusion rates, further reducing potential activation of the inflammatory response 
and other deleterious effects associated with transfusion in this population [20] [21]. 
Previous authors have demonstrated distinct advantages to use of a miniaturized bypass circuit, with docu-
mentation of lower pro-inflammatory cytokines, reduced transfusion requirements, shortened duration of venti-
lation and ICU stay, and reduction in deleterious neurocognitive effects [9]-[14] [19] [22]-[24]. Direct compari-
son with OPCABG has indicated that miniaturized circuits are comparable to OPCABG in terms of inflamma-
tory response generated [24], and may be the desired alternative where OPCABG is not possible. Cardiopulmo-
nary bypass has evolved greatly since its inception, with modifications and improvements in every facet of the 
system. Given the body of work indicating the potential benefits, as well as a growing experience demonstrating 
safety with these systems, it would appear that the miniaturized circuit is the next stage in the evolution of CPB.  
At this center, the MCPBC system has been shown to be comparable to conventional bypass and OPCABG 
with regards to post-operative complications and mortality, though rates for all three modalities are low. The 
MCPBC system group had a non-statistically significant decrease in transfusion requirement compared to con-
ventional bypass and OPCABG, though changes in preoperative vs. postoperative PLT and Hct were not statis-
tically significant. Though these changes did not reach significance, the rates of transfusion and changes in PLT 
and Hct were certainly not worse in the MCPBC group. Based on our observations, a mini-cardiopulmonary 
bypass circuit provides a safe alternative to conventional cardiopulmonary bypass or OPCABG within this pop-
ulation.  
As noted above, a portion of the patients included here underwent CABG with CPB support, but without 
crossclamping and arresting the heart (BHOP). The use of BHOP technique has been debated in the literature, 
and our limited number did not allow specific subgroup analysis of this population here. It should be noted, 
however, that our outcomes in this small subgroup compared favorably to patients receiving OPCABG, and that 
this technique remains a good option for patients who require some measure of support but for whom the risks 
of full arrest and crossclamping are high. The MCPBC system used here functioned well in all cases where a 
BHOP technique was used, and there were no issues with this implementation.  
While our observations were interesting, our study had some important limitations. Our patients were not 
randomized into different groups; the decision regarding which method to use was up to the individual surgeon. 
This lack of randomization led to higher burden of disease individuals being placed in the OPACBG group, as 
evidenced by their higher rate of pre-existing renal failure and preoperative IABP use. The effects of this 
skewed distribution is likely seen in the higher than expected transfusion rates within the OPCABG group, 
though this is purely speculative as our study was not powered to examine this directly. Finally, the small cohort 
studied here makes more robust statistical analyses of the chosen end points impossible and increases the risk of 
type II error.  
One of the previously postulated concerns regarding the implementation of miniaturized CPB systems is their 
applicability to a wide range of cardiac procedures. Previous systems have been marketed for simple procedures, 
primarily isolated CABG. The NovoSci Ready System 200 described here is unique in that it is the first miniatu-
rized system to be specifically designed to handle all cardiac procedures. Though not included in our analysis 
due to low number and inability to compare directly to OPCABG, we performed several complex cardiac cases 
using this system without incident and with outcomes that compared favorably to our standard CPB setup. This 
favorable experience across a wide range of procedures has led to our adoption of a modified miniaturized sys-
tem for 100% of on-pump cases at our facility. 
Though the NovoSci system described here can be utilized for the majority of cardiac procedures, it does have 
some notable drawbacks. The system may be more demanding of the perfusionist, and currently these systems 
are more costly than a typical CPB circuit, presenting obstacles to their widespread adoption. In order to address 
the cost issues, as well as the additional challenges to the perfusionist, we have attempted to modify our standard 
CPB circuit to incorporate the benefits of the MCPBC system. Currently, we are using the Medtronic standard 
circuit, which is Trillium coated with an integrated open venous reservoir, arterial filter, and affinity oxygenator. 
We use the Sorin Revolution for our centrifugal pump and have shortened the lines in our circuit. These shorter 
lines, as well as the routine use of Retrograde Autologous Priming (RAP) have facilitated the reduction of he-
modilution by lowering the prime volume to around 200 ml for most patients. In addition, we have stopped the 
routine use of the cardiotomy suction in an effort to further reduce pro-inflammatory elements. 
These changes to the standard pump setup are relatively simple, and easily implemented in the vast majority 
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of cardiac surgery practices. We believe that these small modifications achieve the best of both the miniaturized 
and conventional circuits and encourage our colleagues to consider similar changes to their standard pump se-
tup. 
5. Conclusion 
The MCPBC system tested here is comparable to conventional bypass and OPCABG in terms of postoperative 
complications and mortality, and may reduce transfusion amounts. A mini-cardiopulmonary bypass circuit pro-
vides a safe alternative to conventional bypass techniques, and can be easily implemented to most practices. 
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